Doctors have long understood that antidepressants can affect heart and metabolic health. A new study from researchers in the U.K. has compiled data from over 150 clinical trials to closely examine the physical side effects of various antidepressants. The research, published in The Lancet, focuses on how these medications impact weight, blood pressure, heart rate, and cholesterol levels.
Dr. Toby Pillinger, a psychiatrist at King’s College London, notes that this analysis is unique. “We created a sort of ‘sports league table’ for 30 different antidepressants based on their side effect profiles,” he explains. This extensive study involved more than 58,000 patients and is the first of its kind to provide specific numbers related to weight gain or changes in cholesterol.
Selective Serotonin Reuptake Inhibitors (SSRIs), such as Zoloft and Prozac, were found to have fewer side effects compared to older antidepressants. For instance, patients taking nortriptyline, a tricyclic antidepressant, might experience a heart rate increase that is 20 beats per minute higher than those on the SSRI fluvoxamine. This comparison highlights the variability in side effects across different medications.
Dr. Pillinger emphasizes that the goal of the study is not to label certain antidepressants as better or worse. “What works for one person may not work for another,” he says. Understanding side effects can help doctors and patients make informed choices about treatment based on individual needs and preferences.
Dr. Nina Kraguljac from Ohio State University, who was not part of the research, praises the study for being thorough and reassuring. She adds, however, that side effects should not single-handedly dictate clinical decisions, as experiences can vary significantly among patients.
One notable limitation of this research is that most data comes from 8-week trials. Consequently, common side effects like sexual dysfunction and emotional blunting weren’t examined. Dr. David Hellerstein from Columbia University points out these gaps, recognizing that some patients could abandon treatment due to such issues.
Meanwhile, user feedback on social media has shown a mix of relief and concern regarding the implications of these findings. Numerous patients express gratitude for a clearer understanding of potential side effects, while some remain cautious about medication use based on personal experiences.
In summary, most antidepressants, especially SSRIs and SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors), appear safe in terms of physical health impacts. However, for certain individuals, side effects can be significant. The goal, ultimately, is to match each patient with the right medication to maximize benefits and minimize adverse effects.
For more in-depth information, you can view the study published in The Lancet here.
